Optimizing Downstream Processing: Innovations, Efficiencies, and Future Directions
June 24, 2026
BioProcess Theatre
Type: BioProcess Session
As biopharmaceutical pipelines grow increasingly diverse — encompassing monoclonal antibodies, recombinant proteins, gene therapies, cell therapies, and other novel modalities — the pressure to streamline and optimize downstream processing (DSP) has never been greater. This panel brings together industry leaders and technical experts to discuss the latest innovations, strategic approaches, and critical pain points in downstream bioprocessing for both traditional biologics and advanced therapies.
From advanced purification technologies such as chromatography, membrane filtration, tangential flow filtration (TFF), ultracentrifugation, and affinity-based methods tailored for proteins, viral vectors, and nucleic acids, to automation, real-time analytics, and platform strategies for scalable manufacturing, our panellists will explore how to improve yield, consistency, and scalability while controlling cost and ensuring product quality.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}